STOCK TITAN

Invivyd (IVVD) CCO’s 40,780-share stock sale runs under 10b5-1 plan

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Invivyd, Inc. (IVVD) reported that Chief Commercial Officer Timothy Edward Lee converted 102,000 restricted stock units into common stock on August 15, 2026, then sold a total of 40,780 common shares in two transactions on August 17–18, 2026. The sales were described as non-discretionary sell-to-cover trades to satisfy tax withholding obligations upon RSU vesting, executed under a Rule 10b5-1 trading plan adopted on February 20, 2025. Reported sale prices are weighted averages across multiple trades within disclosed price ranges.

Positive

  • None.

Negative

  • None.
Insider Lee Timothy Edward
Role Chief Commercial Officer
Sold 40,780 shs ($32K)
Approx. gross sale proceeds $32K
Type Security Shares Price Value
Sale Common Stock F2, F4 18,425 $0.8429 $16K
Sale Common Stock F2, F3 22,355 $0.722 $16K
Exercise Restricted Stock Units F1, F5 102,000 $0.00 $0.00
Exercise Common Stock F1 102,000 -- --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 178,937 shares (Direct)
Footnotes (5)
  1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Shares sold 2026-08-17 22,355 shares at $0.7220 per share Open-market or private sale of common stock on August 17, 2026
Shares sold 2026-08-18 18,425 shares at $0.8429 per share Open-market or private sale of common stock on August 18, 2026
Total shares sold 40,780 shares Aggregate common shares sold across reported sale transactions
RSUs converted 102,000 units Restricted stock units converted into common stock on August 15, 2026
RSU vesting schedule 18 months; one-third every 6 months Vesting terms starting from the February 15, 2025 grant date
Rule 10b5-1 plan adoption date February 20, 2025 Date the reporting person adopted the trading plan used for sell-to-cover transactions
Price range 2026-08-17 $0.682 to $0.830 per share Range of prices for multiple transactions included in the August 17 weighted average
Price range 2026-08-18 $0.760 to $0.872 per share Range of prices for multiple transactions included in the August 18 weighted average
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
sell-to-cover financial
"shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
Rule 10b5-1 plan regulatory
"non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

What insider transactions did IVVD report for Timothy Edward Lee in this Form 4?

Invivyd’s Chief Commercial Officer reported converting 102,000 RSUs into common stock on August 15, 2026, then selling 40,780 shares in two transactions on August 17–18, 2026, primarily to cover tax withholding obligations.

How many Invivyd (IVVD) shares were sold and at what prices in this filing?

A total of 40,780 common shares were sold: 22,355 shares at a weighted average price of $0.722 and 18,425 shares at a weighted average price of $0.8429, each across multiple trades within stated price ranges.

Were the IVVD insider sales by Timothy Edward Lee part of a Rule 10b5-1 plan?

Yes. The filing states that the sell-to-cover transactions were executed under a Rule 10b5-1 plan adopted by Timothy Edward Lee on February 20, 2025, indicating they were pre-arranged rather than discretionary trades.

Why did Invivyd’s CCO sell shares in this IVVD Form 4?

The company reports that the sales were made to satisfy tax withholding obligations arising from the vesting of an RSU award. These non-discretionary sell-to-cover transactions occurred in connection with RSU vesting, not as standalone open-market sales.

What are the vesting terms of the 102,000 Invivyd (IVVD) RSUs reported in this Form 4?

Each of the 102,000 RSUs represents one share of IVVD common stock. The award vests over 18 months, with one-third vesting every six months after the February 15, 2025 grant date, subject to continued service.

How are the sale prices in the IVVD Form 4 characterized?

For each sale date, the filing reports a weighted average price. On August 17, trades ranged from $0.682–$0.830, and on August 18 from $0.760–$0.872, with the insider offering to provide detailed breakdowns on request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lee Timothy Edward

(Last)(First)(Middle)
C/O INVIVYD, INC.
205 CHURCH STREET

(Street)
NEW HAVEN CONNECTICUT 06510

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/15/2026M102,000A(1)219,717D
Common Stock08/17/2026S22,355(2)D$0.722(3)197,362D
Common Stock08/18/2026S18,425(2)D$0.8429(4)178,937D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)08/15/2026M102,000 (5) (5)Common Stock102,000$0.000D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
/s/ Jill Andersen attorney-in-fact for Timothy Edward Lee08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)